Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06400836
Other study ID # Dnr: 2022-03056-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2022
Est. completion date September 2, 2022

Study information

Verified date May 2024
Source Göteborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Physical exercise (PE) significantly influences insulin sensitivity (IS), glucose control and overall metabolic health. While PE effectively enhances IS and glucose regulation, the timing of nutrient intake, before and after exercise, plays a crucial role in modulating its effects. The aim of this study is to evaluate how pre- or post-evening exercise carbohydrate (CHO) ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period and the morning after during an oral glucose tolerance test (OGTT).


Description:

The aim of this study is to evaluate how pre- or post-evening exercise carbohydrate (CHO) ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period and the morning after during an oral glucose tolerance test (OGTT). The primary objective is to assess glucose regulation during a 120-minute OGTT the following day. The secondary objective is to investigate substrate metabolism (CHO and fat oxidation) during a 120-minute OGTT the following day. Ten healthy, well-trained male endurance cyclists/triathletes, aged 19-45 years, are recruited via local contacts from the Gothenburg region, Sweden. The study is performed in accordance with the Declaration of Helsinki 2008 and is approved by the Swedish Ethical Review Authority (Dnr: 2022-03056-01). All participants gave their written informed consent before inclusion. The study has a double-blind, randomized, placebo-controlled, crossover design. After baseline assessment and determination of maximal oxygen uptake (VO2 max), participants undergo a familiarization cycle exercise trial. This trial serves a dual purpose: first, to establish the appropriate amount of CHO to be incorporated into the pre- or post-drink for subsequent cycle experimental trials, and second, to familiarize participants with the equipment and study protocol. Three days prior to the cycle experimental trial, subcutaneous insertion of a glucose sensor for continuous glucose monitoring (CGM) takes place. Participants are randomly assigned to consume either a CHO drink or a placebo (PLA) drink (containing no energy) two hours prior to the cycle experimental trial that starts at 19:30. During the exercise trial, participants engage in submaximal cycling exercise at 70% of their maximal workload (Wmax), followed by a 25-minute time trial (TT). The total duration of the exercise session is approximately 90 minutes. Workload during the TT is individualized based on each participant's maximal work capacity (Wmax). During exercise, capillary glucose levels, heart rate, and rate of perceived exertion (RPE; Borg category scale 6-20) are measured. Additionally, respiratory gases are collected during 5-minute periods at every 15-minute interval to assess substrate utilization. Immediately after completing the TT, participants switch to the opposite drink condition: those who initially received the CHO drink consume the PLA drink, and vice versa. The amount of CHO in the CHO drink consumed by each participant is precisely matched to the amount of CHO that the participant oxidizes during the exercise trial. After the ingestion of the CHO- or placebo drink, participants fast overnight. CGM technology is used to measure interstitial glucose values during the night. At 08:00, participants consume a 300mL solution containing 75g glucose for a 120-min OGTT. Capillary blood samples are collected at baseline and every 15 minutes during the OGTT. Respiratory gases are collected to measure substrate oxidation. The same protocol is reproduced the following week, with the reverse order of the test drink intake. Three days preceding both control and experimental trials, participants are provided with a standardized diet consisting of pre-packaged meals that match their daily energy and macronutrient needs to prevent energy deficiency.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date September 2, 2022
Est. primary completion date September 2, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Females and males - 18-50 years - Endurance fitness level of =40 mL O2/kg/min. - Signed informed consent Exclusion Criteria: • Medical treatment and/or nutritional supplements that may affect glucose tolerance, substrate oxidation and performance capacity

Study Design


Intervention

Other:
Carbohydrate timing - carbohydrate intake before or after exercise
The study aims to investigate how pre- or post evening exercise carbohydrate ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period (21:00-06:00) and the morning after during an 120 minute oral glucose tolerance test (OGTT).

Locations

Country Name City State
Sweden Department of Food and Nutrition, and Sport Science, Centre for Health and Performance, University of Gothenburg, Gothenburg, Sweden Göteborg Bohuslän

Sponsors (2)

Lead Sponsor Collaborator
Göteborg University Örebro University, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other To investigate performance capacity during a cycle ergometer time trial (TT). Performance capacity was assessed by measuring the time (seconds) required to complete a specific amount of work. Comparing the change in performance capacity between the interventions involving carbohydrates being consumed either before (week 1) or after the time trial (week 2). Note that respective arm will be randomized.
Other To investigate substrate oxidation during 50 min submaximal evening exercise. To quantify substrate oxidation rates (carbohydrate oxidation (g/minute) and fat oxidation (g/minute), the change in respiratory exchange ratios will be measured during the 50 min submaximal exercise. Comparing the change in substrate oxidation between the interventions involving previous evening exercise with carbohydrates being consumed either before (week 1) or after exercise (week 2). Note that respective arm will be randomized.
Other To investigate nocturnal glucose regulation. To quantify participants' nocturnal glucose regulation, the change in interstitial glucose levels (mmol/L) will be measured during the period 21:00-06:00 utilizing continuous glucose monitoring (CGM). Comparing the change in glucose levels (mmol/L) during the period 21:00-06:00 between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with CHO consumed either before or after exercise.
Primary To investigate change in glucose tolerance during a 75g glucose, 120 min oral glucose tolerance test (OGTT) To quantify participants' glucose tolerance, the change in plasma glucose levels (mmol/L) will be measured over a 120-minute period following the ingestion of a standardized 75g glucose solution during an OGTT. Comparing the change in glucose tolerance during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with carbohydrates consumed either before or after exercise.
Secondary To investigate substrate oxidation during the oral glucose tolerance test (OGTT) To quantify substrate oxidation rates (carbohydrate oxidation (g/minute) and fat oxidation (g/minute), the change in respiratory exchange ratios (RER) will be measured during the 120-minute OGTT period. Comparing the change in substrate oxidation during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise with carbohydrates being consumed either before or after exercise.
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT04256746 - Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose N/A
Completed NCT03254082 - Glycemic Response of Sorghum N/A
Completed NCT02536066 - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose N/A
Completed NCT00444171 - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients N/A
Completed NCT00302302 - The Effects of L-arabinose on Intestinal Sucrase Activity in Man Phase 1
Completed NCT04378374 - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake N/A
Completed NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery N/A
Recruiting NCT04989712 - MOReS Freestyle Libre Validation Study N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04260425 - A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response N/A
Completed NCT04258501 - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response N/A
Completed NCT02968498 - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers N/A
Completed NCT02484313 - The Effect of Snacks on Glycaemic Regulation in Children N/A
Withdrawn NCT01246492 - The Effect of Artificial Sweeteners on Blood Glucose Response N/A
Completed NCT01241253 - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Phase 2
Completed NCT03914430 - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake N/A
Recruiting NCT05255783 - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients N/A
Completed NCT05573607 - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life N/A
Recruiting NCT05585801 - Continuous Glucose Monitoring in Intensive Care Unit N/A